Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q2 2024 Earnings

15MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-1.19

-1.01

-0.82

-0.64

Details

Expected EPS

-0.79

Actual EPS

-0.73

Surprise EPS

0.06

Surprise Percent

+7.59%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.73 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.